Literature DB >> 16250659

Total synthesis of two novel subpicomolar sarco/endoplasmatic reticulum Ca2+-ATPase inhibitors designed by an analysis of the binding site of thapsigargin.

Helmer Søhoel1, Tommy Liljefors, Steven V Ley, Steven F Oliver, Alessandra Antonello, Martin D Smith, Carl Erik Olsen, John T Isaacs, S Brøgger Christensen.   

Abstract

Analysis of molecular interaction fields based on the published crystal structure of thapsigargin bound to the sarco/endoplasmatic reticulum Ca(2+)-ATPase and analysis of the volume and shape of the ligand binding site and of the SERCA-thapsigargin interactions have enabled design of two new compounds inhibiting SERCA in the subpicomolar range. The two inhibitors were synthesized using (S)-carvone as starting material and found to be 3 and 10 times more potent than thapsigargin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16250659     DOI: 10.1021/jm058036v

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Structure/activity relationship of thapsigargin inhibition on the purified Golgi/secretory pathway Ca2+/Mn2+-transport ATPase (SPCA1a).

Authors:  Jialin Chen; Joren De Raeymaecker; Jannik Brøndsted Hovgaard; Susanne Smaardijk; Ilse Vandecaetsbeek; Frank Wuytack; Jesper Vuust Møller; Jan Eggermont; Marc De Maeyer; Søren Brøgger Christensen; Peter Vangheluwe
Journal:  J Biol Chem       Date:  2017-03-06       Impact factor: 5.157

Review 2.  Targeting thapsigargin towards tumors.

Authors:  Nhu Thi Quynh Doan; Eleonora Sandholdt Paulsen; Pankaj Sehgal; Jesper Vuust Møller; Poul Nissen; Samuel R Denmeade; John T Isaacs; Craig A Dionne; Søren Brøgger Christensen
Journal:  Steroids       Date:  2014-07-24       Impact factor: 2.668

3.  Critical roles of hydrophobicity and orientation of side chains for inactivation of sarcoplasmic reticulum Ca2+-ATPase with thapsigargin and thapsigargin analogs.

Authors:  Anne-Marie L Winther; Huizhen Liu; Yonathan Sonntag; Claus Olesen; Marc le Maire; Helmer Soehoel; Carl-Erik Olsen; S Brøgger Christensen; Poul Nissen; Jesper V Møller
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

Review 4.  Thapsigargin--from Thapsia L. to mipsagargin.

Authors:  Trine Bundgaard Andersen; Carmen Quiñonero López; Tom Manczak; Karen Martinez; Henrik Toft Simonsen
Journal:  Molecules       Date:  2015-04-08       Impact factor: 4.411

Review 5.  Mipsagargin: The Beginning-Not the End-of Thapsigargin Prodrug-Based Cancer Therapeutics.

Authors:  John T Isaacs; William Nathaniel Brennen; Søren Brøgger Christensen; Samuel R Denmeade
Journal:  Molecules       Date:  2021-12-09       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.